Hansa Biopharma AB (publ) (LON: 0RC7)

Hansa Biopharma AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jul 21, 2022	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	159	107	206	323	953	271
Market Cap Growth	47.31%	-47.81%	-36.28%	-66.17%	251.51%	-72.22%
Enterprise Value	189	109	172	242	822	217
Last Close Price	2.36	2.09	3.91	7.24	21.48	6.76
PS Ratio	14.34	10.25	16.70	116.57	1753.27	997.68
PB Ratio	-8.49	-8.18	4.28	5.21	8.61	5.96
P/TBV Ratio	-	-	4.47	5.42	8.83	6.34
EV/Sales Ratio	13.51	10.41	13.96	87.45	1512.21	798.81
Debt / Equity Ratio	-3.00	-5.16	1.31	0.05	0.00	0.02
Asset Turnover	0.18	0.10	0.11	0.03	0.01	0.00
Inventory Turnover	34.61	50.80	63.34	90.74	-	-
Quick Ratio	2.44	2.57	5.91	5.33	12.13	6.41
Current Ratio	2.45	2.66	6.06	5.50	12.20	6.51
Return on Equity (ROE)	-	-382.37%	-89.84%	-54.84%	-46.63%	-50.61%
Return on Assets (ROA)	-37.08%	-36.43%	-26.67%	-27.56%	-25.32%	-27.78%
Return on Capital (ROIC)	-51.97%	-47.09%	-32.93%	-33.06%	-29.20%	-31.20%
Earnings Yield	-30.34%	-60.53%	-23.68%	-13.88%	-3.94%	-10.73%
FCF Yield	-32.43%	-55.02%	-19.61%	-12.24%	-2.72%	-10.06%
Buyback Yield / Dilution	-15.98%	-16.95%	-1.01%	-5.45%	-5.39%	-4.42%
Total Shareholder Return	-15.98%	-16.95%	-1.01%	-5.45%	-5.39%	-4.42%

Source: S&P Capital IQ. Standard template. Financial Sources.